簡易檢索 / 詳目顯示

研究生: 湯婷羽
Tang, Ting-Yu
論文名稱: 探討小分子核醣核酸-196a藉由提升NF-κB活性達到神經保護功效的可能性
Investigate the Possible Effects of miR-196a on Neuroprotection through Nuclear Factor-Keppa B Activation
指導教授: 楊尚訓
Yang, Shang-Hsun
學位類別: 碩士
Master
系所名稱: 醫學院 - 生理學研究所
Department of Physiology
論文出版年: 2015
畢業學年度: 103
語文別: 中文
論文頁數: 80
中文關鍵詞: 小分子核醣核酸-196a神經保護突觸可塑性
外文關鍵詞: miR-196a, neuroprotection, synaptic plasticity
相關次數: 點閱:93下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 在神經元的發育、突觸形成及突觸可塑性的調節中,小分子核醣核酸如何參與這些過程近幾年得到相當多的重視,並且在許多的神經疾病中,如:腦部缺血、神經興奮性毒性及阿茲海默症中,皆曾被報導過小分子核醣核酸有神經保護性功效。本實驗室過去研究指出,在亨丁頓氏手舞足蹈症的細胞、基因轉殖小鼠或人類誘導性多功能幹細胞模式中,特定的小分子核醣核酸-196a具有保護性功效並且改善了病理上及行為學上的表現型態。以上結果暗示,小分子核醣核酸-196a在神經保護作用中扮演重要的角色。近年文獻指出小分子核醣核酸-196a可以藉由抑制IκBα表現量,促使NF-κB活性提升,因此我們推測小分子核醣核酸-196a能藉由調控NF-κB活性而達到神經保護功效。在本篇論文中,我們著重於小分子核醣核酸-196a對神經保護功效中的增加突觸可塑性及增進細胞抗凋亡能力此兩方向進行探討。本論文實驗結果發現在小鼠神經瘤母細胞中及基因轉殖小鼠中,小分子核醣核酸-196a大量表現之後,確實可增加NF-κB的表現量與活性。我們更進一步的發現與突觸可塑性相關的NF-κB目標基因-鈣結合蛋白D-28K在基因轉殖小鼠模式中其蛋白質的表現量有顯著的增加。除此之外,突觸蛋白基因-囊泡相關膜蛋白-1,及與神經活性相關的基因-c fos,在小分子核醣核酸-196a基因轉殖小鼠中也顯著性的提升。此暗示了小分子核醣核酸-196a在基因轉殖小鼠中模式中能提升突觸可塑性及神經活性。另一部分,我們發現在小鼠神經瘤母細胞處於氧化逆境下時,小分子核醣核酸-196a能藉由降低NF-κB目標基因-促凋亡蛋白Bim的表達,進而減少細胞凋亡,增進神經細胞抵抗氧化壓力的能力。綜合我們的結果,發現小分子核醣核酸-196a能提升NF-κB活性,並且也提升了突觸可塑性及增加細胞抗凋亡功能,此發現也許能提供未來對亨丁頓氏手舞足蹈症潛在的治療策略。

    MicroRNAs (miRNAs) have attracted much attention at neuronal development, synapse formation and synaptic plasticity regulation. Besides, emerging evidences suggest that miRNAs are involved in the neuroprotective effects in many neurological disorders, such as brain ischemia, excitotoxicity and Alzheimer's disease. One previous study published from our laboratory indicated that miR-196a ameliorates phenotypes of Huntington’s disease in cells, transgenic mice and patient-derived induced pluripotent stem cell models, indicating that miR-196a may play an important role in neuroprotection. Recently, studies have revealed that miR-196a could directly interact with nuclear factor-keppa B inhibitor alpha (IĸBα) 3'UTR to suppress IκBα expression and subsequently promotes nuclear factor kappa B (NF-κB) activation. Therefore, we hypothesize miR-196a might have neuroprotective effects through NF-ĸB activation. Here, we focuse on the effects of miR-196a on synaptic plasticity and anti-apoptotic functions. Our results suggest that IĸBα is down-regulated and NF-ĸB is activated as miR-196a was overexpressed in cells and transgenic mouse models. Additionally, the brains of miR-196a transgenic mice display higher expression of calbindinD-28k, related to synaptic plasticity. Furthermore, the miR-196a transgenic mice express higher vesicle-associated membrane protein 1 and c-fos, markers for synaptic proteins and neuron activities respectively, compared to those of wild type mice. Besides, miR-196a down-regulates the expression of pro-apoptotic protein Bim and elevates cell viability in the presence of oxidative stress in vitro. Our results identify a possible function of miR-196a on neuroprotection through NF-ĸB activation, and may provide a potential therapeutic strategy for several neurodegenerative diseases.

    摘要 i 誌謝 vi 目錄 vii 圖目錄 xi 壹、文獻探討 1 一、突觸(synapse)生長與突觸可塑性(synaptic plasticity) 1 1.1突觸之定義與生理意義 1 1.2突觸可塑性 1 1.3突觸結構蛋白與調控突觸可塑性的因子 2 二、核因子活化B細胞κ輕鏈增強子(nuclear factor kappa-light-chain-enhancer of activated B cells, NF-κB) 5 2.1歷史 5 2.2NF-κB組成 5 2.3NF-κB的活化調節及與其他訊息傳遞路徑的交互作用 6 2.4NF-κB之功能 8 2.5NF-κB在神經生理方面相關研究 9 2.6NF-κB對於神經存活的相關研究 11 2.7NF-κB對於突觸可塑性及記憶的相關研究 12 三、小分子核醣核酸(microRNA) 13 3.1小分子核醣核酸介紹與功能 13 3.2小分子核醣核酸生合成路徑與基因沉默機制 14 3.3小分子核醣核酸對於突觸可塑性與記憶的相關研究 15 3.4小分子核醣核酸對於NF-κB路徑的調控 16 3.5小分子核醣核酸-196a(miR-196a) 17 貳、研究動機與目標 19 一、研究動機 19 二、研究目標 20 參、材料與方法 21 一、細胞培養 21 1.1細胞株 21 1.2細胞轉染 21 1.3細胞分化 22 二、螢光素酶報導檢測(luciferase reporter assay) 22 三、蛋白質表現量分析 23 3.1細胞及腦部皮質組織蒐集 23 3.2蛋白質萃取 23 3.3蛋白質定量 24 3.4蛋白質變性電泳分析(sodium dodecyl sulfate - polyacrylamide gel electrophoresis, SDS-PAGE) 24 3.5轉漬作用 25 3.6西方墨點法 26 四、核醣核酸表現量分析 27 4.1細胞核醣核酸萃取 27 4.2去除去氧核醣核酸之汙染 27 4.3核醣核酸之反轉錄作用 (reverse transcription) 28 4.4即時聚合酶鏈鎖反應(real-time polymerase chain reaction) 28 4.3核醣核酸之反轉錄作用(reverse transcription) 29 五、免疫螢光染色 30 5.1細胞樣品蒐集固定 30 5.2染色 30 5.3影像分析-NF-κB 31 5.4影像分析-c fos 31 六、免疫組織化學染色 31 6.1組織切片 31 6.2組織染色 31 6.3組織切片c fos染色統計分析 32 七、細胞死亡率分析 33 八、統計分析 33 肆、結果 34 目標一、探討小分子核醣核酸-196a對NF-κB活性的影響 34 1.1探討小分子核醣核酸-196a在神經瘤母細胞中對目標基因IκBα 的3’端不轉譯區的抑制調控作用 34 1.2探討小分子核醣核酸-196a在小鼠神經瘤母細胞及腎上腺髓質嗜鉻細胞瘤中對NF-κB活性的影響 35 1.3探討小分子核醣核酸-196a基因轉殖小鼠腦內NF-κB與IκBα之表現 36 目標二、探討小分子核醣核酸-196a對突觸可塑性之影響 36 2.1研究小分子核醣核酸-196a在離體細胞模式中及在基因轉殖小鼠模式中對與突觸可塑性相關之NF-κB目標基因的影響 36 2.2研究小分子核醣核酸-196a在離體細胞模式中及在基因轉殖小鼠模式中對突觸蛋白的影響 38 2.3研究小分子核醣核酸-196a在離體細胞模式中及在基因轉殖小鼠模式中對神經細胞活性的影響 39 目標三、探討小分子核醣核酸-196a對神經細胞抵抗氧化壓力能力的影響 40 3.1分析小分子核醣核酸-196a在小鼠神經瘤母細胞中對與細胞存活相關之NF-κB目標基因的影響 40 3.2分析小分子核醣核酸-196a在小鼠神經瘤母細胞對氧化逆境下細胞存活率的影響 41 伍、討論 43 一、本論文發現 43 二、鈣結合蛋白D-28K對突觸可塑性及細胞存活的影響 43 三、小分子核醣核酸-196a基因轉殖小鼠突觸蛋白的改變 45 四、突觸蛋白的改變對於神經活性的影響 45 五、小分子核醣核酸-196a對於細胞抵抗氧化逆境的影響 46 六、未來工作 48 陸、結論 49 柒、參考文獻 50 捌、圖表 59

    Ahn, H. J., C. M. Hernandez, J. M. Levenson, F. D. Lubin, H. C. Liou and J. D. Sweatt (2008). "c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation." Learn Mem 15(7): 539-549.
    Albensi, B. C. and M. P. Mattson (2000). "Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity." Synapse 35(2): 151-159.
    Barski, J. J., J. Hartmann, C. R. Rose, F. Hoebeek, K. Morl, M. Noll-Hussong, C. I. De Zeeuw, A. Konnerth and M. Meyer (2003). "Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination." J Neurosci 23(8): 3469-3477.
    Becker, E. B., J. Howell, Y. Kodama, P. A. Barker and A. Bonni (2004). "Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis." J Neurosci 24(40): 8762-8770.
    Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh and D. Baltimore (1995). "Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B." Nature 376(6536): 167-170.
    Beinke, S. and S. C. Ley (2004). "Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology." Biochem J 382(Pt 2): 393-409.
    Bhakar, A. L., L. L. Tannis, C. Zeindler, M. P. Russo, C. Jobin, D. S. Park, S. MacPherson and P. A. Barker (2002). "Constitutive nuclear factor-kappa B activity is required for central neuron survival." J Neurosci 22(19): 8466-8475.
    Bohn, M. C. (2004). "Motoneurons crave glial cell line-derived neurotrophic factor." Exp Neurol 190(2): 263-275.
    Bourassa, C. V., I. A. Meijer, N. D. Merner, K. K. Grewal, M. G. Stefanelli, K. Hodgkinson, E. J. Ives, W. Pryse-Phillips, M. Jog, K. Boycott, D. A. Grimes, S. Goobie, R. Leckey, P. A. Dion and G. A. Rouleau (2012). "VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families." Am J Hum Genet 91(3): 548-552.
    Bui, N. T., A. Livolsi, J. F. Peyron and J. H. Prehn (2001). "Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha." J Cell Biol 152(4): 753-764.
    Carter, B. D., C. Kaltschmidt, B. Kaltschmidt, N. Offenhauser, R. Bohm-Matthaei, P. A. Baeuerle and Y. A. Barde (1996). "Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75." Science 272(5261): 542-545.
    Castagne, V., K. Lefevre and P. G. Clarke (2001). "Dual role of the NF-kappaB transcription factor in the death of immature neurons." Neuroscience 108(3): 517-526.
    Cauley, K. and I. M. Verma (1994). "Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain." Proc Natl Acad Sci U S A 91(1): 390-394.
    Chaudhuri, A. D., S. Kabaria, D. C. Choi, M. M. Mouradian and E. Junn (2015). "MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death." J Biol Chem 290(19): 12425-12434.
    Chen, L. F., Y. Mu and W. C. Greene (2002). "Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB." EMBO J 21(23): 6539-6548.
    Cheng, P. H., C. L. Li, Y. F. Chang, S. J. Tsai, Y. Y. Lai, A. W. Chan, C. M. Chen and S. H. Yang (2013). "miR--196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models." Am J Hum Genet 93(2): 306-312.
    Choi, D. C., Y. J. Chae, S. Kabaria, A. D. Chaudhuri, M. R. Jain, H. Li, M. M. Mouradian and E. Junn (2014). "MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA." J Neurosci 34(38): 12725-12737.
    Conboy, L., R. Bisaz, K. Markram and C. Sandi (2010). "Role of NCAM in emotion and learning." Adv Exp Med Biol 663: 271-296.
    Connors, B. W. and M. A. Long (2004). "Electrical synapses in the mammalian brain." Annu Rev Neurosci 27: 393-418.
    Cruz, F. C., E. Koya, D. H. Guez-Barber, J. M. Bossert, C. R. Lupica, Y. Shaham and B. T. Hope (2013). "New technologies for examining the role of neuronal ensembles in drug addiction and fear." Nat Rev Neurosci 14(11): 743-754.
    Davila, D., E. M. Jimenez-Mateos, C. M. Mooney, G. Velasco, D. C. Henshall and J. H. Prehn (2014). "Hsp27 binding to the 3'UTR of bim mRNA prevents neuronal death during oxidative stress-induced injury: a novel cytoprotective mechanism." Mol Biol Cell 25(21): 3413-3423.
    Del Signore, S. J., D. J. Amante, J. Kim, E. C. Stack, S. Goodrich, K. Cormier, K. Smith, M. E. Cudkowicz and R. J. Ferrante (2009). "Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice." Amyotroph Lateral Scler 10(2): 85-94.
    Denis-Donini, S., A. Dellarole, P. Crociara, M. T. Francese, V. Bortolotto, G. Quadrato, P. L. Canonico, M. Orsetti, P. Ghi, M. Memo, S. A. Bonini, G. Ferrari-Toninelli and M. Grilli (2008). "Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice." J Neurosci 28(15): 3911-3919.
    Denk, A., T. Wirth and B. Baumann (2000). "NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival." Cytokine Growth Factor Rev 11(4): 303-320.
    Duckworth, E. A., T. Butler, L. Collier, S. Collier and K. R. Pennypacker (2006). "NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice." Brain Res 1088(1): 167-175.
    Earls, L. R., J. J. Westmoreland and S. S. Zakharenko (2014). "Non-coding RNA regulation of synaptic plasticity and memory: Implications for aging." Ageing Res Rev.
    El-Husseini, A. E., E. Schnell, D. M. Chetkovich, R. A. Nicoll and D. S. Bredt (2000). "PSD-95 involvement in maturation of excitatory synapses." Science 290(5495): 1364-1368.
    Filipowicz, W., S. N. Bhattacharyya and N. Sonenberg (2008). "Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?" Nat Rev Genet 9(2): 102-114.
    Fleischmann, A., O. Hvalby, V. Jensen, T. Strekalova, C. Zacher, L. E. Layer, A. Kvello, M. Reschke, R. Spanagel, R. Sprengel, E. F. Wagner and P. Gass (2003). "Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS." J Neurosci 23(27): 9116-9122.
    Franzoso, G., L. Carlson, L. Poljak, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, P. Love, K. Brown and U. Siebenlist (1998). "Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture." J Exp Med 187(2): 147-159.
    Freudenthal, R., F. Locatelli, G. Hermitte, H. Maldonado, C. Lafourcade, A. Delorenzi and A. Romano (1998). "Kappa-B like DNA-binding activity is enhanced after spaced training that induces long-term memory in the crab Chasmagnathus." Neurosci Lett 242(3): 143-146.
    Freudenthal, R. and A. Romano (2000). "Participation of Rel/NF-kappaB transcription factors in long-term memory in the crab Chasmagnathus." Brain Res 855(2): 274-281.
    Gaiarsa, J. L., O. Caillard and Y. Ben-Ari (2002). "Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance." Trends Neurosci 25(11): 564-570.
    Gao, C., M. B. Gill, N. C. Tronson, A. L. Guedea, Y. F. Guzman, K. H. Huh, K. A. Corcoran, G. T. Swanson and J. Radulovic (2010). "Hippocampal NMDA receptor subunits differentially regulate fear memory formation and neuronal signal propagation." Hippocampus 20(9): 1072-1082.
    Gao, J., W. Y. Wang, Y. W. Mao, J. Graff, J. S. Guan, L. Pan, G. Mak, D. Kim, S. C. Su and L. H. Tsai (2010). "A novel pathway regulates memory and plasticity via SIRT1 and miR-134." Nature 466(7310): 1105-1109.
    Gerrow, K. and A. Triller (2010). "Synaptic stability and plasticity in a floating world." Curr Opin Neurobiol 20(5): 631-639.
    Ghosh, S., M. J. May and E. B. Kopp (1998). "NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses." Annu Rev Immunol 16: 225-260.
    Glazewski, S., K. P. Giese, A. Silva and K. Fox (2000). "The role of alpha-CaMKII autophosphorylation in neocortical experience-dependent plasticity." Nat Neurosci 3(9): 911-918.
    Grumolato, L., A. G. Elkahloun, H. Ghzili, D. Alexandre, C. Coulouarn, L. Yon, J. P. Salier, L. E. Eiden, A. Fournier, H. Vaudry and Y. Anouar (2003). "Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion." Endocrinology 144(6): 2368-2379.
    Guo, Q., S. Christakos, N. Robinson and M. P. Mattson (1998). "Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function." Proc Natl Acad Sci U S A 95(6): 3227-3232.
    Hansen, K. F., K. Karelina, K. Sakamoto, G. A. Wayman, S. Impey and K. Obrietan (2013). "miRNA-132: a dynamic regulator of cognitive capacity." Brain Struct Funct 218(3): 817-831.
    Hartz, B. P. and L. C. Ronn (2010). "NCAM in long-term potentiation and learning." Adv Exp Med Biol 663: 257-270.
    Huang, F., J. Tang, X. Zhuang, Y. Zhuang, W. Cheng, W. Chen, H. Yao and S. Zhang (2014). "MiR--196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha." PLoS One 9(2): e87897.
    Huxford, T., S. Malek and G. Ghosh (1999). "Structure and mechanism in NF-kappa B/I kappa B signaling." Cold Spring Harb Symp Quant Biol 64: 533-540.
    Jiang, L., C. Lin, L. Song, J. Wu, B. Chen, Z. Ying, L. Fang, X. Yan, M. He, J. Li and M. Li (2012). "MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop." J Clin Invest 122(1): 33-47.
    Jung, E. M., K. C. Choi and E. B. Jeung (2011). "Expression of calbindin-D28k is inversely correlated with proapototic gene expression in hydrogen peroxide-induced cell death in endometrial cancer cells." Int J Oncol 38(4): 1059-1066.
    Kaltschmidt, B., D. Ndiaye, M. Korte, S. Pothion, L. Arbibe, M. Prullage, J. Pfeiffer, A. Lindecke, V. Staiger, A. Israel, C. Kaltschmidt and S. Memet (2006). "NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling." Mol Cell Biol 26(8): 2936-2946.
    Kaltschmidt, C., B. Kaltschmidt and P. A. Baeuerle (1993). "Brain synapses contain inducible forms of the transcription factor NF-kappa B." Mech Dev 43(2-3): 135-147.
    Kim, B. W., S. Koppula, H. Kumar, J. Y. Park, I. W. Kim, S. V. More, I. S. Kim, S. D. Han, S. K. Kim, S. H. Yoon and D. K. Choi (2015). "alpha-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease." Neuropharmacology.
    Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton and S. Gerondakis (1995). "Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression." Genes Dev 9(16): 1965-1977.
    Korner, M., A. Rattner, F. Mauxion, R. Sen and Y. Citri (1989). "A brain-specific transcription activator." Neuron 3(5): 563-572.
    Kosik, K. S. (2006). "The neuronal microRNA system." Nat Rev Neurosci 7(12): 911-920.
    Kovalenko, A., C. Chable-Bessia, G. Cantarella, A. Israel, D. Wallach and G. Courtois (2003). "The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination." Nature 424(6950): 801-805.
    Kwon, S. E. and E. R. Chapman (2011). "Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons." Neuron 70(5): 847-854.
    Lawrence, T. (2009). "The nuclear factor NF-kappaB pathway in inflammation." Cold Spring Harb Perspect Biol 1(6): a001651.
    Lewis, B. P., C. B. Burge and D. P. Bartel (2005). "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets." Cell 120(1): 15-20.
    Lin, L. F., D. H. Doherty, J. D. Lile, S. Bektesh and F. Collins (1993). "GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons." Science 260(5111): 1130-1132.
    Lisman, J., H. Schulman and H. Cline (2002). "The molecular basis of CaMKII function in synaptic and behavioural memory." Nat Rev Neurosci 3(3): 175-190.
    Lisman, J., R. Yasuda and S. Raghavachari (2012). "Mechanisms of CaMKII action in long-term potentiation." Nat Rev Neurosci 13(3): 169-182.
    Liu, Y., Y. Sugiura and W. Lin (2011). "The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction." J Physiol 589(Pt 7): 1603-1618.
    Loewi, O. (1957). "On the background of the discovery of neurochemical transmission." J Mt Sinai Hosp N Y 24(6): 1014-1016.
    Loftis, J. M. and A. Janowsky (2003). "The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications." Pharmacol Ther 97(1): 55-85.
    Lu, Z. Y., S. P. Yu, J. F. Wei and L. Wei (2006). "Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice." Neuroscience 139(3): 965-978.
    Lugli, G., V. I. Torvik, J. Larson and N. R. Smalheiser (2008). "Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain." J Neurochem 106(2): 650-661.
    Manecka, D. L., S. F. Mahmood, L. Grumolato, I. Lihrmann and Y. Anouar (2013). "Pituitary adenylate cyclase-activating polypeptide (PACAP) promotes both survival and neuritogenesis in PC12 cells through activation of nuclear factor kappaB (NF-kappaB) pathway: involvement of extracellular signal-regulated kinase (ERK), calcium, and c-REL." J Biol Chem 288(21): 14936-14948.
    Maness, P. F. and M. Schachner (2007). "Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration." Nat Neurosci 10(1): 19-26.
    Mattson, M. P. and S. Camandola (2001). "NF-kappaB in neuronal plasticity and neurodegenerative disorders." J Clin Invest 107(3): 247-254.
    Meberg, P. J., W. R. Kinney, E. G. Valcourt and A. Routtenberg (1996). "Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity." Brain Res Mol Brain Res 38(2): 179-190.
    Meffert, M. K., J. M. Chang, B. J. Wiltgen, M. S. Fanselow and D. Baltimore (2003). "NF-kappa B functions in synaptic signaling and behavior." Nat Neurosci 6(10): 1072-1078.
    Mellios, N., H. Sugihara, J. Castro, A. Banerjee, C. Le, A. Kumar, B. Crawford, J. Strathmann, D. Tropea, S. S. Levine, D. Edbauer and M. Sur (2011). "miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity." Nat Neurosci 14(10): 1240-1242.
    Mincheva-Tasheva, S. and R. M. Soler (2013). "NF-kappaB signaling pathways: role in nervous system physiology and pathology." Neuroscientist 19(2): 175-194.
    Mincheva, S., A. Garcera, M. Gou-Fabregas, M. Encinas, X. Dolcet and R. M. Soler (2011). "The canonical nuclear factor-kappaB pathway regulates cell survival in a developmental model of spinal cord motoneurons." J Neurosci 31(17): 6493-6503.
    Moerman, A. M., X. Mao, M. M. Lucas and S. W. Barger (1999). "Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB." Brain Res Mol Brain Res 67(2): 303-315.
    Nakajima, K. and S. Kohsaka (1998). "Functional roles of microglia in the central nervous system." Hum Cell 11(3): 141-155.
    Nickols, J. C., W. Valentine, S. Kanwal and B. D. Carter (2003). "Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation." Nat Neurosci 6(2): 161-167.
    Odero, G. L., K. Oikawa, K. A. Glazner, J. Schapansky, D. Grossman, J. D. Thiessen, A. Motnenko, N. Ge, M. Martin, G. W. Glazner and B. C. Albensi (2010). "Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease." Neuroscience 169(1): 532-543.
    Oeckinghaus, A., M. S. Hayden and S. Ghosh (2011). "Crosstalk in NF-kappaB signaling pathways." Nat Immunol 12(8): 695-708.
    Olarerin-George, A. O., L. Anton, Y. C. Hwang, M. A. Elovitz and J. B. Hogenesch (2013). "A functional genomics screen for microRNA regulators of NF-kappaB signaling." BMC Biol 11: 19.
    Paratcha, G., F. Ledda and C. F. Ibanez (2003). "The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands." Cell 113(7): 867-879.
    Pizzi, M., F. Goffi, F. Boroni, M. Benarese, S. E. Perkins, H. C. Liou and P. Spano (2002). "Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta." J Biol Chem 277(23): 20717-20723.
    Popovic, R., L. E. Riesbeck, C. S. Velu, A. Chaubey, J. Zhang, N. J. Achille, F. E. Erfurth, K. Eaton, J. Lu, H. L. Grimes, J. Chen, J. D. Rowley and N. J. Zeleznik-Le (2009). "Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization." Blood 113(14): 3314-3322.
    Potluri, V., S. K. Noothi, S. D. Vallabhapurapu, S. O. Yoon, J. J. Driscoll, C. H. Lawrie and S. Vallabhapurapu (2013). "Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma." PLoS One 8(7): e66121.
    Sananbenesi, F., A. Fischer, C. Schrick, J. Spiess and J. Radulovic (2002). "Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1." Mol Cell Neurosci 21(3): 463-476.
    Scheller, R. H. (2013). "In search of the molecular mechanism of intracellular membrane fusion and neurotransmitter release." Nat Med 19(10): 1232-1235.
    Schmidt-Ullrich, R., S. Memet, A. Lilienbaum, J. Feuillard, M. Raphael and A. Israel (1996). "NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity." Development 122(7): 2117-2128.
    Sen, R. and D. Baltimore (1986). "Multiple nuclear factors interact with the immunoglobulin enhancer sequences." Cell 46(5): 705-716.
    Sheng, M. (2001). "The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain." J Cell Sci 114(Pt 7): 1251.
    Siegel, G., G. Obernosterer, R. Fiore, M. Oehmen, S. Bicker, M. Christensen, S. Khudayberdiev, P. F. Leuschner, C. J. Busch, C. Kane, K. Hubel, F. Dekker, C. Hedberg, B. Rengarajan, C. Drepper, H. Waldmann, S. Kauppinen, M. E. Greenberg, A. Draguhn, M. Rehmsmeier, J. Martinez and G. M. Schratt (2009). "A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis." Nat Cell Biol 11(6): 705-716.
    Sim, S. E., J. Bakes and B. K. Kaang (2014). "Neuronal Activity-Dependent Regulation of MicroRNAs." Mol Cells.
    Sindreu, C. B., Z. S. Scheiner and D. R. Storm (2007). "Ca2+ -stimulated adenylyl cyclases regulate ERK-dependent activation of MSK1 during fear conditioning." Neuron 53(1): 79-89.
    Snow, W. M., B. M. Stoesz, D. M. Kelly and B. C. Albensi (2014). "Roles for NF-kappaB and gene targets of NF-kappaB in synaptic plasticity, memory, and navigation." Mol Neurobiol 49(2): 757-770.
    Song, L., L. Liu, Z. Wu, Y. Li, Z. Ying, C. Lin, J. Wu, B. Hu, S. Y. Cheng, M. Li and J. Li (2012). "TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets." J Clin Invest 122(10): 3563-3578.
    Soontornniyomkij, V., V. B. Risbrough, J. W. Young, B. Soontornniyomkij, D. V. Jeste and C. L. Achim (2012). "Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice." Neurosci Lett 516(1): 161-165.
    Sparacio, S. M., Y. Zhang, J. Vilcek and E. N. Benveniste (1992). "Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein." J Neuroimmunol 39(3): 231-242.
    Stefanits, H., C. Wesseling and G. G. Kovacs (2014). "Loss of Calbindin immunoreactivity in the dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias." Neurosci Lett 566: 137-141.
    Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel and P. Herrlich (1993). "Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function." EMBO J 12(10): 3879-3891.
    Sweatt, J. D. (2001). "Memory mechanisms: the yin and yang of protein phosphorylation." Curr Biol 11(10): R391-394.
    Tanzer, A., C. T. Amemiya, C. B. Kim and P. F. Stadler (2005). "Evolution of microRNAs located within Hox gene clusters." J Exp Zool B Mol Dev Evol 304(1): 75-85.
    Vo, N., M. E. Klein, O. Varlamova, D. M. Keller, T. Yamamoto, R. H. Goodman and S. Impey (2005). "A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis." Proc Natl Acad Sci U S A 102(45): 16426-16431.
    Wang, H., E. Hertlein, N. Bakkar, H. Sun, S. Acharyya, J. Wang, M. Carathers, R. Davuluri and D. C. Guttridge (2007). "NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes." Mol Cell Biol 27(12): 4374-4387.
    Wang, T., W. P. Lafuse and B. S. Zwilling (2001). "NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium." J Immunol 167(12): 6924-6932.
    Wayman, G. A., Y. S. Lee, H. Tokumitsu, A. J. Silva and T. R. Soderling (2008). "Calmodulin-kinases: modulators of neuronal development and plasticity." Neuron 59(6): 914-931.
    Yang, G., D. Han, X. Chen, D. Zhang, L. Wang, C. Shi, W. Zhang, C. Li, X. Chen, H. Liu, D. Zhang, J. Kang, F. Peng, Z. Liu, J. Qi, X. Gao, J. Ai, C. Shi and S. Zhao (2014). "MiR--196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IkappaBalpha both in vitro and in vivo." Neuro Oncol 16(5): 652-661.
    Yeh, S. H., C. H. Lin and P. W. Gean (2004). "Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory." Mol Pharmacol 65(5): 1286-1292.
    Yeh, S. H., C. H. Lin, C. F. Lee and P. W. Gean (2002). "A requirement of nuclear factor-kappaB activation in fear-potentiated startle." J Biol Chem 277(48): 46720-46729.
    Yekta, S., I. H. Shih and D. P. Bartel (2004). "MicroRNA-directed cleavage of HOXB8 mRNA." Science 304(5670): 594-596.
    Yenari, M. A., M. Minami, G. H. Sun, T. J. Meier, D. M. Kunis, J. R. McLaughlin, D. Y. Ho, R. M. Sapolsky and G. K. Steinberg (2001). "Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia." Stroke 32(4): 1028-1035.
    Yilmaz, Z. B., D. S. Weih, V. Sivakumar and F. Weih (2003). "RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF." EMBO J 22(1): 121-130.
    Yu, Z., D. Zhou, A. J. Bruce-Keller, M. S. Kindy and M. P. Mattson (1999). "Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury." J Neurosci 19(20): 8856-8865.
    Yu, Z., D. Zhou, G. Cheng and M. P. Mattson (2000). "Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease." J Mol Neurosci 15(1): 31-44.
    Zhong, H., R. E. Voll and S. Ghosh (1998). "Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300." Mol Cell 1(5): 661-671.

    無法下載圖示 校內:2020-08-26公開
    校外:不公開
    電子論文尚未授權公開,紙本請查館藏目錄
    QR CODE